RESUMO
BACKGROUND: Blood infections with multidrug-resistant Gram-negative carbapenem-resistant bacilli are particularly dangerous and challenging to treat in organ transplant recipients. Resistance to carbapenems may be acquired, for example, in Enterobacteriaceae, Pseudomonas, or Acinetobacter spp. or innate, for example, in Stenotrophomonas maltophilia. The purpose of this study was to analyze blood infections caused by S maltophilia in organ transplant recipients and to compare drug susceptibility of these bacteria and the same species isolated from the blood of other inpatients. METHODS: A total of 26 S maltophilia strains isolated from blood samples of 26 patients (including 14 liver or kidney transplant recipients) hospitalized during 2011 to 2014 were evaluated in this study. Antibiotic susceptibility was determined via E-test and disk diffusion methods. RESULTS: Stenotrophomonas maltophilia strains isolated from blood exhibited sensitivity to trimethoprim/sulfamethoxazole (100%), levofloxacin (96.2%), ciprofloxacin (92.3%), ticarcillin/clavulanic acid (80.8%), and ceftazidime (53.9%). CONCLUSIONS: Because appropriate antibiotic therapy in the case of S maltophilia differs from the standard empirical therapy administered in the case of most other Gram-negative bacilli, early identification of this pathogen is of particular significance. The use of antibiotics to which this pathogen is sensitive eliminates the infection and helps avoid graft loss.
Assuntos
Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Infecções por Bactérias Gram-Negativas/microbiologia , Testes de Sensibilidade Microbiana , Transplante de Órgãos/efeitos adversos , Antibacterianos/uso terapêutico , Ceftazidima/uso terapêutico , Ciprofloxacina/uso terapêutico , Ácidos Clavulânicos/uso terapêutico , Farmacorresistência Bacteriana , Hospitais de Ensino , Humanos , Levofloxacino/uso terapêutico , Stenotrophomonas maltophilia , Ticarcilina/uso terapêutico , Transplantados/estatística & dados numéricos , Combinação Trimetoprima e Sulfametoxazol/uso terapêuticoRESUMO
INTRODUCTION: Organ transplantation for many patients with end-stage liver disease is a life-saving operation. Progressing at a time and usually irreversible damage to the organ directly leads to many life-threatening complications as well as to progressive deterioration in health and the quality of life (QOL). On the other hand, the assessment of QOL after liver transplantation, apart from the survival analysis, should take into account general health perception, physical activity, a place in the family and in the environment, as well as the patient's social and professional activity. MATERIAL AND METHODS: The study group included 238 patients (128 women and 110 men) who underwent transplantation in various transplantation centers in Warsaw due to chronic and acute liver failure. To measure the QOL the author's questionnaire was used, which was made especially for this study. RESULTS: There were no significant correlations found between the subjective QOL of the examined patients and socio-demographic and clinical variables, such as age, gender, education, marital status, occupational status, and time from the organ transplantation. However, a significant correlation was found between the perceived QOL of patients and the following variables: physical activity, pain and other symptoms, social and family life, sex life, and psycho-emotional state. It was also proved that the problems with maintaining a normal body weight after liver transplantation significantly affected the overall health of patients. CONCLUSIONS: Liver transplantation in the vast majority of patients, despite numerous complaints, facilitates functioning in various fields of life. On the other hand, the indicated discomfort in the area of mental and emotional health requires easier access to a psychologist. At the same time, there is a justified requirement for education and nutritional counselling for patients after liver transplantation because of the proven risk of occurrence of cardiovascular disease.
Assuntos
Transplante de Fígado/psicologia , Qualidade de Vida/psicologia , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Inquéritos e Questionários , Resultado do TratamentoRESUMO
BACKGROUND: Using expanded criteria donor (ECD) organs is 1 strategy to make more organs available for transplant. To reduce the number of posttransplant complications and failures, there is a need to create a comprehensive system of evaluation before transplantation, especially for kidneys harvested from ECD. The aim of this study was to assess the results of kidneys procured from ECD seeking to discover the most useful factors for kidney evaluation before transplantation. PATIENTS AND METHODS: One hundred seventy-two patients received cadaveric renal transplants between January 1, 2006, and August 31, 2008. We collected data on donors, recipients, and perfusion parameters. We analyzed patient and graft survivals, as well as immediate, delayed, and slow graft function. Kidney recipient function was assessed by serum creatinine concentrations and by creatinine clearance calculated according to the Cockroft-Gault formula. Renal biopsy specimens were obtained in the perioperative periods 147 cases. RESULTS: The overall 1-year graft survival was 86.9%. More than 25% of transplanted kidneys were harvested from ECD. There were no significant differences in patient survival between recipients of standard criteria donor kidneys (RSCDK) versus of expanded criteria donor kidneys (RECDK). One-year graft survival was higher among the RSCDK group than the RECDK group, namely, 94.4% versus 62.5%, (P = .004). There were no differences in the incidence of primary nonfunction or in delayed graft function between the groups. RECDK were more likely to show slow graft function (69.2% vs 37.8%; P = .033). A lower graft survival at 6 months after transplantation was observed among organs harvested from ECD compared with standard criteria donor (SCD) kidneys who showed histologic lesions or a flow at the fourth hour of machine perfusion below 0.4 mL/g. Using a logistic regression model, chronic histologic changes were shown to influence kidney survival at 6 months after transplantation. CONCLUSION: There was no significant difference in patient survival between recipients of kidneys harvested from expanded versus standard criteria donors. ECD kidneys displayed lower graft survival rates. There was no significant difference in the incidence of delayed graft function between recipients of kidneys harvested from expanded versus standard criteria donors. Pretransplant evaluation of ECD kidneys should include 3 variables: donor parameters, histologic findings, and machine perfusion parameters.
Assuntos
Transplante de Rim/estatística & dados numéricos , Seleção de Pacientes , Doadores de Tecidos/estatística & dados numéricos , Obtenção de Tecidos e Órgãos/métodos , Biópsia , Cadáver , Creatinina/sangue , Creatinina/metabolismo , Feminino , Seguimentos , Sobrevivência de Enxerto/fisiologia , Humanos , Transplante de Rim/mortalidade , Transplante de Rim/patologia , Masculino , Nefrectomia , Estudos Retrospectivos , Taxa de Sobrevida , Fatores de Tempo , Resultado do TratamentoRESUMO
INTRODUCTION: The aim of this study was an economic evaluation of three sirolimus (SRL)-based regimens in the first 2 years after renal transplantation. MATERIALS AND METHODS: The three SRL-based immunosuppressive regimens in renal transplant patients between June 2000 and September 2002 were: (1) SRL + steroids + cyclosporine (CsA) permanently; (2) SRL + steroids + tacrolimus (Tac); and (3) SRL + steroids + CsA, with CsA discontinuation at 3 months posttransplant. Ten patients were included in each group in an intent-to-treat analysis. Cost was calculated according to the hospital price list and recast into euros (EUR) with a 5% discount rate. RESULTS: The number of patients free of an acute rejection episode during 2 years posttransplant were 6, 8, and 5, with 2-year graft and patient survivals of 9, 10, and 9 for regimens 1, 2, and 3, respectively. As differences in clinical effects were not statistically significant, cost analysis was appropriate instead of cost-effectiveness analysis. The mean cost of the 2-year treatment was 15,759 EUR; 25,593 EUR; and 21,197 EUR per patient for regimens 1, 2, and 3, respectively. Sensitivity analysis for the main variables confirmed that the results were not dependent on changes in costs. CONCLUSIONS: Regimen 1 was the most economical immunosuppressive therapy during the 2 years after kidney transplantation. Studies on a larger group of longer observation would be more useful for clinical analysis.
Assuntos
Transplante de Rim/imunologia , Sirolimo/uso terapêutico , Adulto , Idoso , Efeitos Psicossociais da Doença , Feminino , Rejeição de Enxerto/epidemiologia , Sobrevivência de Enxerto/fisiologia , Teste de Histocompatibilidade , Humanos , Imunossupressores/economia , Imunossupressores/uso terapêutico , Falência Renal Crônica/classificação , Falência Renal Crônica/cirurgia , Transplante de Rim/economia , Transplante de Rim/mortalidade , Masculino , Pessoa de Meia-Idade , Polônia , Estudos Retrospectivos , Sirolimo/economia , Análise de Sobrevida , Doadores de Tecidos/classificaçãoRESUMO
INTRODUCTION: Biliary complications are known as the weak point of liver transplantation. Their occurrence can be related to the practice of drainage of the biliary anastomosis, the routine use of which was abandoned in June 2004. The aim of the study was to assess the incidence and type of biliary complications following orthotopic liver transplantation in relation to the technique of biliary anastomosis. MATERIAL AND METHODS: We compared the results of two groups of adult liver transplant recipients: group I, recent 50 transplantations with biliary drainage (25 women: 25 men of age range: 17 to 63 years), and group II, first 50 transplantations without drainage (19 women and 31 men of age range, 20 to 65 years). We examined the problem of biliary complications and their influence on the further management of the patients. In both groups the main indications for transplantation were various types of cirrhosis as well as cholestatic diseases. In the majority of cases (n = 86) an end-to-end common bile duct anastomosis was performed and in 14 cases, hepaticojejunal anastomosis. RESULTS: In group I, biliary complications requiring surgical or endoscopic intervention occurred in 10 (20%) recipients. In one case, biliary complications resulted in the need for retransplantation. In group II, biliary complications occurred in only four (8%) patients, none of which caused organ loss. CONCLUSION: Cessation of biliary anastomosis drainage has reduced the occurrence of early biliary complications following orthotopic liver transplantation.
Assuntos
Sistema Biliar/diagnóstico por imagem , Doenças da Vesícula Biliar/epidemiologia , Vesícula Biliar/cirurgia , Transplante de Fígado/efeitos adversos , Procedimentos de Cirurgia Plástica/métodos , Adolescente , Adulto , Anastomose Cirúrgica/métodos , Ductos Biliares Intra-Hepáticos/diagnóstico por imagem , Colangiografia , Feminino , Doenças da Vesícula Biliar/etiologia , Humanos , Abscesso Hepático/diagnóstico por imagem , Abscesso Hepático/etiologia , Masculino , Pessoa de Meia-IdadeRESUMO
The aim of this study was to assess the usefulness of liver grafts procured from "marginal donors." Among 62 liver transplants in 2002, almost half were harvested from donors who were not deemed acceptable by other transplant units. The authors compared the data concerning the donor's status with the function of the transplanted liver. The relations between individual parameters were estimated, as well as the differences between two groups of recipients: those who received a graft from the "poorer" donors versus those who received "better" grafts. Regardless of the relations between particular parameters a statistical analysis revealed that differences of liver function that were detected during the first 5 days after transplantation disappeared thereafter.